Pharmacogenetic aspects in treatment of colorectal cancer – an update

Author： Stoehlmacher Jan   Goekkurt Eray   Lenz Heinz-Josef  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.4, Iss.6, 2003-11, pp. : 767-777

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients

By Cortejoso Lucía   López-Fernández Luis A  

Pharmacogenomics, Vol. 13, Iss. 10, 2012-07 ,pp. : 1173-1191

Future Medicine

Access to resources Recommend Favorite

VEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 update

By Eng Lawson   Liu Geoffrey  

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1659-1667

Future Medicine

Access to resources Recommend Favorite

Colorectal cancer screening - an update from the ACG

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 262, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Pharmacogenetic aspects of bipolar disorder

By Alda Martin  

Pharmacogenomics, Vol. 4, Iss. 1, 2003-01 ,pp. : 35-40

Future Medicine

Access to resources Recommend Favorite

Panitumumab: In the Treatment of Metastatic Colorectal Cancer

By Hoy Sheridan M.   Wagstaff Antona J.  

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 2005-2014

Adis International

Access to resources Recommend Favorite